Peripheral neuropathy decisions — 2025

The Board denied increased ratings for PTSD, diabetes mellitus, type II, and hypothyroidism while granting increased ratings for peripheral neuropathy in the right and left lower extremities, hearing loss (left ear), and a compensable evaluation for scars, burns (2nd degree).

The Board granted service connection for obstructive sleep apnea, resolving reasonable doubt in favor of the Veteran. The claims for left and right lower extremity peripheral neuropathy were remanded due to inadequate medical opinions.

The Board granted restoration of service connection for peripheral neuropathy in both the left and right upper extremities, finding that the original severance was improper due to clear and unmistakable error related to Agent Orange exposure.

The Board dismissed the appeals for service connection for bilateral pes planus and a left knee disability due to improper docketing, while remanding claims for lower extremity neuropathy and restless leg syndrome for further development.

The Board remands the claims for specially adapted housing and special home adaptation due to a pre-decisional error in not obtaining a medical opinion.

The Board granted an earlier effective date of June 17, 2021 for the grant of entitlement to individual unemployability due to service-connected disabilities and restored a 50 percent rating for other unspecified anxiety disorder and a 10 percent disability rating for hypertension.

The Board granted an effective date of October 20, 2008 for the award of service connection for left and right lower extremity peripheral neuropathy.

The Board granted an effective date of February 9, 2023, for the increased ratings of 40 percent for right upper extremity diabetic peripheral neuropathy and 30 percent for left upper extremity diabetic peripheral neuropathy.

The Board granted service connection for the Veteran's low back disability, cervical spine condition, and peripheral neuropathy in both lower extremities, resolving all doubt in favor of the Veteran.

The Board granted a disability rating of 40 percent for the Veteran's left hand peripheral neuropathy and 30 percent for his right hand peripheral neuropathy, effective February 9, 2024.

The Board granted service connection for tinnitus and denied service connection for hypertension, coronary artery disease (CAD), diabetes mellitus, type I and II, right foot osteoarthritis, headaches, steatosis, and diabetic peripheral neuropathy.

The appeal regarding the eligibility to direct payment of attorney fees is remanded for corrective notice due to errors in the May 2024 fee decision.

The Board granted service connection for colorectal cancer, lung cancer, spinal cancer, neuropathy in the thoracic paraspinal region, a bilateral circulatory disability of the lower extremities, a bilateral skin disability of the lower extremities, residuals of a stroke as secondary to hypertension, and cause of death. Some issues were remanded.

The Board denied service connection for various conditions, including carpal tunnel syndrome, radiculopathy, and peripheral neuropathy, as the evidence did not support a finding that these conditions began during active service or were related to in-service exposure to herbicide agents.

The Board granted service connection for chronic headaches but denied service connection for right knee disability, left knee disability, neurological condition, peripheral neuropathy of the right upper and lower extremities, and skin cancer.

The Board remands the issues of entitlement to increased ratings for service-connected peripheral neuropathy of both upper extremities due to insufficient notice for a scheduled examination.

The Board denied the veteran's claims for service connection for sensory peripheral neuropathy of both lower extremities, as there was no evidence to support a finding that these conditions were related to his active-duty service.

The Board granted a 30 percent rating for residuals of a gunshot wound to the left upper (non-dominant) arm with left upper extremity peripheral neuropathy, but denied a compensable rating for bilateral hearing loss.

The Board denied the claims for an earlier effective date for service connection for diabetes mellitus type II with diabetic neuropathy and sleep apnea, as well as the claim for service connection for obesity.

The Board denied service connection for vertigo and remanded the claims for right upper extremity peripheral neuropathy, left upper extremity peripheral neuropathy, and right lower extremity peripheral neuropathy.